Table 1 Prevalence of CL among patients who visited the BMH Dermatology Department from 2012 to 2018
Year | Examined | Â | CL positive | |||
Male, n (%) | Female, n (%) | Total | Male, n (%) | Female, n (%) | Total, n (%) | |
2012 | 2327 (53.6) | 2016 (46.4) | 4343 | 26 (1.1) | 15 (0.7) | 41 (0.9) |
2013 | 3363 (51.8) | 3129 (48.2) | 6492 | 27 (0.8) | 14 (0.5) | 41 (0.6) |
2014 | 3181 (54.6) | 2644 (45.4) | 5825 | 34 (1.1) | 13 (0.5) | 47 (0.8) |
2015 | 4779 (53.8) | 4102 (46.2) | 8881 | 29 (0.6) | 23 (0.6) | 52 (0.6) |
2016 | 4664 (49.9) | 4683 (50.1) | 9347 | 38 (0.8) | 30 (0.6) | 68 (0.7) |
2017 | 7507 (48.4) | 8014 (51.6) | 15,521 | 221 (2.9) | 149 (1.9) | 370 (2.4) |
2018* | 3883 (50.1) | 3871 (49.9) | 7,754 | 168 (4.3) | 101 (2.6) | 269 (3.5) |
Total | 29,704 (51.1) | 28,459 (48.9) | 58,163 | 543 (1.8) | 345 (1.2) | 888 (1.5) |